Serving as a field-based extension of Medical Affairs, the Medical Science Liaison (MSL) will represent the Company and its surgical product portfolio by developing long-term relationships with critical stakeholders, including but not limited to healthcare professionals (General, Reconstructive, Abdominal Surgeons) in addition to key healthcare decisions makers, key opinion leaders, clinicians, academic institutions, and managed care organizations. The MSL will address the specific needs of these groups by engaging in discussions on the Company’s product/s for post-surgical pain, in addition to future pipeline products, that are timely, fair-balanced, and objective.
The Medical Science Liaison (MSL) is the front-line member of the Medical Affairs organization responsible for establishing and maintaining educational and research collaborations with a primary responsibility of engaging in the exchange of published scientific data and other medical and/or scientific information with external customers (Health Care Providers, researchers, professional organization leadership, and formulary decision-makers). The MSL will initially focus on the Company’s pipeline product, a late-stage, surgically implantable product in development to provide sustained postsurgical pain relief.
The MSL will deliver clinical, scientific, and technical education, building long term peer to peer relationships with key stakeholders by establishing rapport and providing scientific education to key surgical and O.R. healthcare practitioners. The MSL is responsible for developing, coordinating and assuring implementation of corporate, scientific, and clinical strategies to these thought leaders within academic, clinical, and healthcare organizations. These scientific exchanges will support and/or expand current concepts, as well as ensure the safe and effective utilization of the Company's product(s).